Bone Marrow Aplasia and Neutropenic Fever Following Azathioprine Dose Escalation in a TPMT-Deficient Patient with Crohn’s Disease and Psoriatic Arthritis—A CARE–Compliant Case
<b>Background:</b> Myelotoxicity, usually manifested by moderate leukopenia (particularly neutropenia), is a well-known adverse drug reaction to azathioprine (AZA) therapy. Thiopurine methyltransferase (<i>TMPT</i>) and nucleoside diphosphate-linked moiety X-type motif 15 (&l...
Saved in:
| Main Authors: | Krzysztof Wroński, Michał Tadeusz Holecki, Natalia Boguszewska, Marzena Skrzypczak-Zielińska, Jerzy Tadeusz Chudek |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Clinics and Practice |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2039-7283/15/6/114 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PTPN2 and Leukopenia in Individuals With Normal TPMT and NUDT15 Metabolizer Status Taking Azathioprine
by: Laura L. Daniel, et al.
Published: (2025-06-01) -
Thiopurine S-methyl Transferase (TPMT) Enzyme Level in Healthy Sudanese Population
by: Rayan Khalid, et al.
Published: (2024-09-01) -
Diarrhea in neutropenic children with cancer: An Egyptian center experience, with emphasis on neutropenic enterocolitis
by: Laila M Sherief, et al.
Published: (2012-01-01) -
Investigating neutropenic enterocolitis: a systematic review of case reports and clinical insights
by: Samane Nematolahi, et al.
Published: (2025-01-01) -
Is neutropenia still the main risk factor for invasive aspergillosis? A contemporary university hospital retrospective cohort of invasive aspergillosis in neutropenic and non-neutropenic patients
by: Andrea Gutiérrez-Villanueva, et al.
Published: (2025-04-01)